OK Spotted a mistake in this weeks FA prospects... the very 1st entry in the list from Tobyjack ...ORN should be OSL. Here is the corrected entry ... Appols
OSL recently announced global strategic manufacturing alliance (co-operation and costs sharing agreement) with Eckert & Ziegler, a leader in the manufacture of devices, radiochemicals and radiopharmaceutical precursors used in the treatment of serious diseases and for medical imaging.Also they have recently taken a step towards commercialising its pancreatic cancer treatment medical device OncoSil™ with the initiating of a gap analysis assessment that will define the pathway to a pre Investigation Device Exemption (IDE) meeting with the U.S. Food and Drug Administration (FDA).OSL is developing OncoSil™ as an implantable device that emits radiation directly into the pancreatic tumour, and the pain conducting nerves surrounding it.The company is seeking to register OncoSil™ as a medical device in all major markets as they have a fraction of the development cost compared to drugs and are faster to register, making for a better return on investment.OncoSil Medical received a notice of initial substantial shareholder from WebInvest as trustee for OLSB Unit Trust, which acquired 12,432,673 shares or a 5.14% stake. WebInvest is run by Otto Buttula, former founder/CEO of IWL which he sold to CBA and walked away with almost $52.5 million Had $3.5mil cash in the bank as at last quarter Spotted by: Tobyjack
